{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:59:00Z","timestamp":1788044340612,"version":"build-2784847793"},"reference-count":32,"publisher":"European Respiratory Society (ERS)","issue":"1","funder":[{"DOI":"10.13039\/100002291","name":"Pulmonary Hypertension Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T35HL105350"],"award-info":[{"award-number":["T35HL105350"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007875","name":"Tulane University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2018,1,18]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Pulmonary hypertension is a potentially fatal disease. Despite pharmacological advances in pulmonary hypertension, fatigue remains common in patients with pulmonary hypertension.<\/jats:p><jats:p>A convenience sample of 120 participants at an international patient conference completed the Multidimensional Fatigue Inventory (MFI)-20 scale. Data on New York Heart Association Functional Class, body mass index, oxygen use and medication type\/use were also collected.<\/jats:p><jats:p>There was a high prevalence of \u201csevere\u201d to \u201cvery severe\u201d fatigue for each dimension: General Fatigue (60%), Physical Fatigue (55.8%), Reduced Activity (41.7%), Reduced Motivation (32.5%) and Mental Fatigue (27.5%). The mean\u00b1<jats:sc>sd<\/jats:sc>overall MFI-20 score was 58\u00b15.1. Dimensions with the highest averaged levels were General Fatigue (13.40\u00b13.61), Physical Fatigue (13.23\u00b13.67) and Reduced Activity (11.33\u00b14.16). Body mass index correlated with higher fatigue scores. Phosphodiesterase inhibitor plus endothelin receptor antagonist combination negatively predicted General Fatigue, Physical Fatigue, Reduced Motivation and Reduced Activity. Triple therapy was a significant predictor of General Fatigue, Physical Fatigue and Reduced Activity. There were no significant predictors of Mental Fatigue.<\/jats:p><jats:p>Multidimensional fatigue is common and severe in patients with pulmonary hypertension. Phosphodiesterase inhibitor plus endothelin receptor antagonist combination resulted in lower scores in most fatigue dimensions. Comprehensive assessment of fatigue should be considered in the clinical care of patients with pulmonary hypertension and clinical research to develop formal interventions that target this disabling symptom.<\/jats:p>","DOI":"10.1183\/23120541.00079-2017","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T08:50:12Z","timestamp":1521795012000},"page":"00079-2017","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors"],"prefix":"10.1183","volume":"4","author":[{"given":"Todd M.","family":"Tartavoulle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryn C.","family":"Karpinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benzi M.","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2018,3,23]]},"reference":[{"key":"2024101707043446000_4.1.00079-2017.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0075"},{"key":"2024101707043446000_4.1.00079-2017.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2012.08.010"},{"key":"2024101707043446000_4.1.00079-2017.3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f07be"},{"key":"2024101707043446000_4.1.00079-2017.4","first-page":"A3306","article-title":"Fatigue may have an impact on functioning and quality of life equal to that of dyspnea in patients with pulmonary hypertension","volume":"187","author":"Saketkoo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101707043446000_4.1.00079-2017.5","doi-asserted-by":"publisher","DOI":"10.1177\/1049909114554079"},{"key":"2024101707043446000_4.1.00079-2017.6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1260"},{"key":"2024101707043446000_4.1.00079-2017.7","first-page":"A3302","article-title":"The World Health Organization's (WHO) International Classification of Functioning Health and Disability (ICF): an emerging language for pulmonary hypertension","volume":"187","author":"Saketkoo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101707043446000_4.1.00079-2017.8","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000145593.37594.39"},{"key":"2024101707043446000_4.1.00079-2017.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsams.2012.05.014"},{"key":"2024101707043446000_4.1.00079-2017.10","doi-asserted-by":"publisher","DOI":"10.1177\/1352458513493684"},{"key":"2024101707043446000_4.1.00079-2017.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2012.04.004"},{"key":"2024101707043446000_4.1.00079-2017.12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21949"},{"key":"2024101707043446000_4.1.00079-2017.13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.0000000000000587","article-title":"Prevalence of fatigue in Parkinson disease and its clinical correlates","volume":"83","author":"Stocchi","year":"2014","journal-title":"Neurology"},{"key":"2024101707043446000_4.1.00079-2017.14","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)00125-O"},{"key":"2024101707043446000_4.1.00079-2017.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0653-z"},{"key":"2024101707043446000_4.1.00079-2017.16","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-7-18"},{"key":"2024101707043446000_4.1.00079-2017.17","doi-asserted-by":"publisher","DOI":"10.1067\/mhl.2002.124554"},{"key":"2024101707043446000_4.1.00079-2017.18","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.42"},{"key":"2024101707043446000_4.1.00079-2017.19","doi-asserted-by":"publisher","DOI":"10.1002\/art.20539"},{"key":"2024101707043446000_4.1.00079-2017.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413687"},{"key":"2024101707043446000_4.1.00079-2017.21","doi-asserted-by":"publisher","DOI":"10.1002\/pon.1890"},{"key":"2024101707043446000_4.1.00079-2017.22","doi-asserted-by":"publisher","DOI":"10.1177\/1534735413492727"},{"key":"2024101707043446000_4.1.00079-2017.23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-15"},{"key":"2024101707043446000_4.1.00079-2017.24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00520-014-2181-8","article-title":"Effect of dance on cancer-related fatigue and quality of life","volume":"22","author":"Sturm","year":"2014","journal-title":"Support Care Cancer"},{"key":"2024101707043446000_4.1.00079-2017.25","doi-asserted-by":"publisher","DOI":"10.3109\/02699052.2012.700082"},{"key":"2024101707043446000_4.1.00079-2017.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2013.06.005"},{"key":"2024101707043446000_4.1.00079-2017.27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt181"},{"key":"2024101707043446000_4.1.00079-2017.28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jclinepi.2015.08.037","article-title":"PROMIS fatigue item bank had clinical validity across diverse chronic conditions","volume":"73","author":"Cella","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2024101707043446000_4.1.00079-2017.29","doi-asserted-by":"publisher","DOI":"10.1177\/1474515114537951"},{"key":"2024101707043446000_4.1.00079-2017.30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep287"},{"key":"2024101707043446000_4.1.00079-2017.31","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-005-3513-4"},{"key":"2024101707043446000_4.1.00079-2017.32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpainsymman.2015.07.012","article-title":"Symptom interference severity and health-related quality of life in pulmonary arterial hypertension","volume":"51","author":"Matura","year":"2016","journal-title":"J Pain Symptom Manage"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00079-2017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T04:55:37Z","timestamp":1740372937000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00079-2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3,23]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1183\/23120541.00079-2017"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00079-2017","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}